Flow Neuroscience Launches FDA-Approved FL-100 At-Home tDCS Treatment in the US

Flow Neuroscience announced that FL-100 is now available by prescription across the United States, introducing the first FDA-approved at-home transc...

September 18, 2026 | Friday | News
Boehringer Ingelheim Launches PED Essentials to Strengthen Patient Experience Data

Ingelheim, Germany - Boehringer Ingelheim announced the launch of PED Essentials, a comprehensive e-learning hub designed to help patient organizations g...

September 18, 2026 | Friday | News
Aptar Pharma and Massachusetts General Hospital Partner to Advance Nose-to-Brain Drug Delivery

AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, announced that it has...

September 16, 2026 | Wednesday | News
Nanobiotix Reports Positive Phase 1 Data for JNJ-1900 in Recurrent NSCLC

All 24 patients completed treatment with no dose-limiting toxicities, no Grade 3 or higher adverse events related to JNJ-1900 (NBTXR3 or to the injecti...

September 15, 2026 | Tuesday | News
Bio Usawa and Axmed Collaborate to Expand Access to Affordable Biologics Across Africa

Bio Usawa and Axmed have entered into a strategic collaboration to expand patient access to advanced, affordable biologic medicines across African health...

September 15, 2026 | Tuesday | News
Seismic Pharmaceuticals Enrols First Patient in Global Phase III Istaroxime Trial for Cardiogenic Shock

Approximately 600 patients expected to be enrolled at clinical sites across the United States, Europe, China and South America Global Phase 3 program, R...

September 11, 2026 | Friday | News
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered Rentosertib for IPF

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced that it has dosed the first patien...

September 11, 2026 | Friday | News
Bone Biologics Expands NB1 Spine Fusion Trial to Six Australian Hospital Sites

Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for s...

September 10, 2026 | Thursday | News
Tarsus Completes Alkeus Acquisition to Add Phase 3 Stargardt Disease Program

Adds gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt’s disea...

September 08, 2026 | Tuesday | News
NexLife Expands Compounded GLP-1 Program With Four Protocols Under Flat-Rate Pricing Model

NexLife, a LegitScript-certified, physician-led telehealth platform, announced that its compounded GLP-1 program now spans four protocols under a single ...

September 02, 2026 | Wednesday | News
10x Genomics Wins $4.8 Million Patent Infringement Verdict Against Parse Biosciences

10x Genomics, Inc., the life science technology leader focused on accelerating science and advancing human health, announced that a jury in the U.S. Dist...

August 31, 2026 | Monday | News
Roche Reports Positive Two-Year Vabysmo Data in Polypoidal Choroidal Vasculopathy

Roche announced new two-year data from the Phase IIIb/IV SALWEEN study of Vabysmo® (faricimab), presented at the 19th Asia-Pacific Vitreo-retina Soci...

August 31, 2026 | Monday | News
Teva Bids to Acquire BioXcel’s Novel At-Home Neuroscience Treatment for Agitation

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. announced it has made a bid to acquire an innovative neurosc...

August 31, 2026 | Monday | News
Globus Medical Acquires Higgs Boson Health to Advance Digital Healthcare and Surgical Intelligence

Globus Medical, Inc., a leading musculoskeletal technology company, announced the acquisition of Higgs Boson Health, a digital healthcare experience comp...

August 28, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close